Dr. Walsh obtained his MD in 2001, completed internal medicine in 2005, Nephrology training in 2006 and a MSc in Community Health Science in 2008 all at the University of Calgary. He then trained in lupus and vasculitis in Cambridge, UK as KRESCENT fellow until 2009, followed by a PhD in Health Research Methods at McMaster University until 2014 under a RCT Mentorship Award from CIHR. He is now an Associate Professor of Medicine (Nephrology) and Health Research Methods, Evidence & Impact at McMaster University, medical director of the Glomerulonephritis Clinic and the director of the Clinical Nephrology Research Group at St. Joseph’s Healthcare, and Scientist at the Population Health Research Institute where he leads research investigating treatments for patients with kidney diseases.
135
0
0
Date (UTC+8) | Time (UTC+8) | Local Time | Hall | Session | Role | Talk Title |
---|---|---|---|---|---|---|
2022-06-18 | 14:45-15:00 | 2022-06-18,14:45-15:00 | Hall 2 |
Improving Outcomes in Diabetic Kidney Disease and Beyond - Session 28 |
Speaker | Mineralocorticoid receptor antagonists - What roles do they play in CKD and DKD ? |